Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin with FOLFIRI and Bevacizumab in Advanced Colorectal Cancer
NCT00323011Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- May 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dalteparin in venous thromboembolism (VTE) (3 arms), sponsored by University of Southern California. Primary endpoint: Levels of blood-clotting factors. Started May 2006; status: terminated.
02
Drugs
dalteparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00323011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323011.